Uses of epoetin for anemia in oncology.
Seidenfeld
J
J
Aronson
N
N
Piper
M
M
Flamm
C R
CR
Hasselblad
V
V
Ziegler
K M
KM
D000743:Anemia, Hemolytic / Q000188:drug therapy* / Q000209:etiology*; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D016465:Bone Marrow Purging / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D015994:Incidence; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins; D018570:Risk Assessment; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D011994:Recombinant Proteins; D004921:Erythropoietin